IOF World Congress on Osteoporosis

Back to Homepage

Satellite Symposia
(updated 26.4.2002)

Friday, May 10, 2002
17:15 – 19:00 (Auditorium 1)

Risedronate Therapy: Current Understandings, Clinical Applications and Future Directions

Sponsor: The Alliance for Better Bone Health (Aventis Pharma and Procter & Gamble Pharmaceuticals)

Chair: H. Fleisch

Programme:

Understanding differences in bisphosphonate pharmacology
G. Russell

New insights into the relationship between bone turnover and fracture risk reduction
P.D. Delmas

Risedronate in the treatment of osteoporosis – future directions
R. Lindsay

Risedronate in the treatment of osteoarthritis: A unique bisphosphonate application
T. Spector